spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  CardiAQ 

 HSMN NewsFeed - 1 Jun 2026
Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 24 May 2023
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 21 Mar 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 6 Nov 2017
Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 12 Sep 2017
Neovasc Provides Tiara(TM) Clinical Update
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2017
Neovasc's Reducer System Reviewed in European Heart Journal
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Dec 2016
Neovasc Provides Update on its Tiara(TM) Mitral Valve Clinical Program
Devices Cardiology Surgery
 HSMN NewsFeed - 1 Nov 2016
Neovasc Announces Update in Litigation with CardiAQ
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 9 Oct 2014
Neovasc Receives FDA Conditional Approval to Initiate TIARA-I Trial in US: A Multinational, Multicenter Early Feasibility Trial of the Tiara(TM) Transcatheter Mitral Valve
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Apr 2014
CardiAQ(TM) Valve Technologies Inc. (CardiAQ) appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance & Clinical Affairs
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 14 Jun 2012
CardiAQ(TM) Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Feb 2011
CardiAQ Valve Technologies (CVT) appoints Dr. Kalathi Thyagarajan as Vice President of Regulatory Affairs & Quality Assurance
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 1 Jun 2010
CardiAQ Valve Technologies ("CVT") Completes Move of Its Headquarters to a Specialized Facility in Irvine, Calif., and Announces Expansion of Its Product Development Team
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
CardiAQ Valve Technologies ("CVT") to Disclose Data During "EuroPCR 2010" About the World's First Successful In Vivo Transcatheter Delivery of a Mitral Heart Valve Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jan 2010
CardiAQ Valve Technologies (CVT) Closes $6.5 Million 'Series A' Funding for Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Sep 2009
CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System
Devices Interventional Cardiology
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!